Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA regs and other documents

This article was originally published in The Tan Sheet

Executive Summary

HHS Secretary Shalala informs OMB Director Leon Panetta in a March 29 memo that she has "reviewed and approved for publication in the Federal Register" FDA regulations and documents that have been on hold at OMB since January when Panetta put a hold on pending federal regs until Clinton Administration officials could review them. FDA sent OMB a list of 30 regs pending publication that included some OTC drug monograph final rules. Shalala also authorized future publication of regs not subject to the "Reservation of Authority" or her personal review.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081294

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel